세계의 항체 단편 시장 보고서(2025년)

Antibody Fragments Global Market Report 2025

US $ 4,490 ￦ 6,521,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,426,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,330,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

항체 단편 시장 규모는 향후 몇 년간 강력한 성장이 예상될 예정입니다. 자가면역질환에의 응용 확대, 이중 특이성 항체의 출현 등에 기인하는 것으로 예측됩니다.

대상 질환의 유병률 상승은 향후 수 년간 항체 단편 시장의 성장을 견인할 것으로 예측됩니다. 일반적인 대상 질환으로는 암, 감염증, 세균 감염증 등이 있습니다. 건강 문제의 한 원인이 되고 있습니다. 항체 단편은 다양한 질환에 대해 매우 특이적이고 적당한 다용도의 치료법을 제공하며, 많은 경우 기존의 치료법에 비해 부작용이 적은 것이 특징입니다. 특정 목표에 맞게 설계할 수 있기 때문에 현대 의학에서 매우 귀중한 도구가 되고 있습니다. American Cancer Society(미국암협회)는 2025년에는 미국에서 새롭게 204만 1,910명의 암 환자 발생과 61만 8,120명의 암 관련 사망이 발생할 것으로 예상되며, 이는 2024년 신규 환자수 200만 1,140명, 사망자 수 61만 1,720명 보다 증가한 수치라고 보고했습니다. 이와 같이, 대상 질환의 유병률 증가가 항체 단편 시장의 확대에 박차를 가하고 있습니다.

항체 단편 시장의 주요 기업은 인간 VH 항체 단편과 같은 혁신적인 제품을 개발하기 위한 임상시험의 실시에 주력하고 있으며, 암, 자가면역 질환, 감염증의 치료에 있어서 표적 요법의 효능을 향상시키고, 면역원성을 저감시키는 것을 목표로 하고 있습니다. 중쇄의 가변 도메인으로, 독립적으로 항원에 결합할 수 있습니다. 중요한 항원 결합 영역으로서 기능하는 것으로 항체 단편을 형성해, 소형이고 안정한 고친화성의 치료 및 진단용 항체를 제작하기 위해, 단독 또는 다른 분자와 조합해 사용됩니다. 2024년 5월, 중국에 본사를 둔 제약 회사인 자이 랩(Zai Lab Limited)은 IL-17을 표적으로 하는 새로운 인간 VH 항체 단편(Humabody)인 ZL-1102의 효능과 안전성을 평가하는 국제 공동 2상 임상시험을 시작했습니다. 이 치료는 경도에서 중등도의 만성 심상성 건선에 대한 외용 요법으로 개발되어 전신성 부작용과 면역원성 반응을 최소화하면서 치료 정밀도 향상을 목표로 하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 태와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 항체 단편 시장의 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
• 최종 이용 산업의 분석
• 세계의 항체 단편 시장 : 성장률 분석
• 세계의 항체 단편 시장 실적 : 규모와 성장, 2019-2024년
• 세계의 항체 단편 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 항체 단편 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 항체 단편 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• F(ab)단편
• F(ab')2 단편
• 단쇄 가변 단편(scFv)
• 단일 도메인 항체 단편(sdAbs)
• 기타
• 세계의 항체 단편 시장 : 특이성별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 단일클론항체
• 폴리클로날 항체
• 세계의 항체 단편 시장 : 투여 방법별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 정맥내(IV)
• 피하(SC)
• 경구
• 경피
• 세계의 항체 단편 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 암
• 면역 결핍
• 기타
• 세계의 항체 단편 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 제약회사
• 바이오테크놀러지 기업
• 연구기관
• 진단실험실
• 계약연구기관(CRO)
• 세계의 항체 단편 시장 : F(ab) 단편의 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 재조합 F(ab) 단편
• 효소 유도 F(ab) 단편
• 세계의 항체 단편 시장 : F(ab')2 단편의 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 펩신 유래 F(ab')2 단편
• 재조합 F(ab')2 단편
• 세계의 항체 단편 시장 : 단쇄 가변 단편(scFv)의 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 세균 생산 단쇄 가변 단편(scFv)
• 포유류 세포 생산 단쇄 가변 단편(scFv)
• 효모 생산 단쇄 가변 단편(scFv)
• 세계의 항체 단편 시장 : 단일 도메인 항체 단편(sdAbs)의 세분화: 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 낙타과 동물 유래 단일 도메인 항체 단편(sdAbs)
• 상어 유래 단일 도메인 항체 단편(sdAbs)
• 합성 단일 도메인 항체 단편(sdAbs)
• 세계의 항체 단편 시장 : 기타 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 이중특이적 항체 단편
• 다중특이적 항체 단편
• 융합 단백질 항체 단편

제7장 지역별/국가별 분석

• 세계의 항체 단편 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 항체 단편 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

• 항체 단편 시장 : 경쟁 구도
• 항체 단편 시장 : 기업 프로파일
  • Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Johnson & Johnson Services Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
  • F. Hoffmann-La Roche AG : 개요, 제품 및 서비스, 전략 및 재무 분석
  • AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• AstraZeneca PLC
• Novartis AG
• GSK plc
• Eli Lilly and Company
• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Regeneron Pharmaceuticals Inc.
• Biogen Inc.
• UCB SA
• Bio-Rad Laboratories Inc.
• Genmab A/S
• WuXi Biologics Co. Ltd.
• Abcam plc
• MacroGenics Inc.
• Harbour BioMed

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 항체 단편 시장 2029 : 새로운 기회를 제공하는 국가
• 항체 단편 시장 2029 : 새로운 기회를 제공하는 부문
• 항체 단편 시장 2029 : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

SHW

영문 목차

영문목차

Antibody fragments are smaller portions of full-length antibodies that retain the ability to bind to specific antigens. These fragments are derived from antibodies and are designed to offer advantages such as greater stability, better tissue penetration, and reduced immune system reactions, making them valuable for both therapeutic and diagnostic uses.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of antibody fragments include F(ab) fragments, F(ab')2 fragments, single-chain variable fragments (scFvs), single-domain antibody fragments (sdAbs), and other types. F(ab) fragments are specific fragments that have a single antigen-binding site, lacking the Fc region to minimize immune interactions, which enhances their use in diagnostics and therapy. Antibody fragments can be classified as either monoclonal or polyclonal antibodies based on their specificity. These fragments are administered through various methods, including intravenous (IV), subcutaneous (SC), oral, or transdermal routes. They are used for treating conditions such as cancer, immunodeficiencies, and other medical disorders. The key end users of antibody fragments include pharmaceutical companies, biotechnology firms, research institutions, diagnostic labs, and contract research organizations (CROs).

The antibody fragments market research report is one of a series of new reports from The Business Research Company that provides antibody fragments market statistics, including the antibody fragments industry global market size, regional shares, competitors with the antibody fragments market share, detailed antibody fragments market segments, market trends, and opportunities, and any further data you may need to thrive in the antibody fragments industry. This antibody fragments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The antibody fragments market size has grown strongly in recent years. It will grow from $10.35 billion in 2024 to $11.37 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to the rising prevalence of chronic diseases, increased adoption of biologics, growth in cancer therapeutics, regulatory approvals for antibody-based treatments, and the expansion of biopharmaceutical research.

The antibody fragments market size is expected to see strong growth in the next few years. It will grow to $16.44 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing investment in research and development of biologics, growing preference for smaller antibody formats, rising demand for personalized medicine, expanding applications in autoimmune diseases, and the emergence of bispecific antibodies. Major trends in the forecast period include the integration of AI-driven drug discovery, development of cost-effective production methods, collaborations between biotech firms, advancements in monoclonal antibody technology, and a focus on antibody-drug conjugates.

The rising prevalence of target diseases is expected to drive the growth of the antibody fragments market in the coming years. Target diseases refer to specific conditions or illnesses that medical treatments, therapies, or research aim to prevent, manage, or cure. Common target diseases include cancer, infectious diseases, and bacterial infections. The increasing prevalence of these diseases is primarily attributed to unhealthy lifestyles and pollution, which weaken the body's defenses and contribute to chronic health issues. Antibody fragments offer highly specific, targeted, and versatile treatment options for a variety of diseases, often with fewer side effects compared to traditional therapies. Their ability to be tailored and engineered for specific targets makes them an invaluable tool in modern medicine. For example, in January 2025, the American Cancer Society, a U.S.-based nonprofit organization, reported that in 2025, the United States is expected to see 2,041,910 new cancer cases and 618,120 cancer-related deaths, up from 2,001,140 new cases and 611,720 deaths in 2024. Thus, the growing prevalence of target diseases is fueling the antibody fragments market's expansion.

Leading companies in the antibody fragments market are focusing on conducting clinical trials to develop innovative products, such as human VH antibody fragments, to improve the effectiveness of targeted therapies and reduce immunogenicity when treating cancers, autoimmune disorders, and infectious diseases. A human VH antibody fragment is the variable domain of the heavy chain of a human antibody, capable of binding to antigens independently. It forms antibody fragments by serving as the crucial antigen-binding region and is often used alone or in combination with other molecules to create small, stable, high-affinity therapeutic or diagnostic antibodies. For instance, in May 2024, Zai Lab Limited, a China-based pharmaceutical company, initiated a global Phase 2 clinical trial to assess the efficacy and safety of ZL-1102, a novel human VH antibody fragment (Humabody) targeting IL-17. This treatment is being developed as a topical therapy for mild-to-moderate chronic plaque psoriasis, aimed at improving treatment precision while minimizing systemic side effects and immunogenic responses.

In September 2024, Valerio Therapeutics S.A., a clinical-stage biotechnology company based in France, acquired Emglev Therapeutics for an undisclosed sum. This acquisition enhances Valerio Therapeutics' antibody discovery capabilities by incorporating Emglev Therapeutics' synthetic single-domain antibody (sdAb) technology, further expanding its therapeutic applications. Emglev Therapeutics is a biotechnology firm based in France, specializing in the development of synthetic single-domain antibodies (sdAb).

Major players in the antibody fragments market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Novartis AG, GSK plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Biogen Inc., UCB S.A., Bio-Rad Laboratories Inc., Genmab A/S, WuXi Biologics Co. Ltd., Abcam plc, MacroGenics Inc., Harbour BioMed, Creative Biolabs Inc.

North America was the largest region in the antibody fragments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antibody fragments report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the antibody fragments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antibody fragments market consists of revenues earned by entities by providing services such as pharmacokinetics and toxicology testing, clinical and regulatory support services, custom conjugation services, and antibody fragment production and expression services. The market value includes the value of related goods sold by the service provider or included within the service offering. The antibody fragments market also includes sales of diabodies and tribodies, nanobodies, antibody-based therapeutics, and diagnostic agents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antibody Fragments Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antibody fragments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antibody fragments ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antibody fragments market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: F(ab) Fragments; F(ab')2 Fragments; Single-Chain Variable Fragments (scFvs); Single Domain Antibody Fragments (sdAbs); Other Types
• 2) By Specificity: Monoclonal Antibody; Polyclonal Antibody
• 3) By Delivery Method: Intravenous (IV); Subcutaneous (SC); Oral; Transdermal
• 4) By Application: Cancer; Immunodeficiencies; Other Applications
• 5) By End User: Pharmaceutical Companies; Biotechnology Companies; Research Institutions; Diagnostic Laboratories; Contract Research Organizations (CROs)
• Subsegments:
• 1) By F(ab) Fragments: Recombinant F(ab) Fragments; Enzymatically Derived F(ab) Fragments
• 2) By F(ab')2 Fragments: Pepsin-Derived F(ab')2 Fragments; Recombinant F(ab')2 Fragments
• 3) By Single-Chain Variable Fragments (scFvs): Bacterial-Produced Single-Chain Variable Fragments (scFvs); Mammalian Cell-Produced Single-Chain Variable Fragments (scFvs); Yeast-Produced Single-Chain Variable Fragments (scFvs)
• 4) By Single Domain Antibody Fragments (sdAbs): Camelid-Derived Single Domain Antibody Fragments (sdAbs); Shark-Derived Single Domain Antibody Fragments (sdAbs); Synthetic Single Domain Antibody Fragments (sdAbs)
• 5) By Other Types: Bispecific Antibody Fragments; Multispecific Antibody Fragments; Fusion Protein Antibody Fragments
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche AG; AbbVie Inc.; Sanofi S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Antibody Fragments Market Characteristics

3. Antibody Fragments Market Trends And Strategies

4. Antibody Fragments Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Antibody Fragments Growth Analysis And Strategic Analysis Framework

• 5.1. Global Antibody Fragments PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Antibody Fragments Market Growth Rate Analysis
• 5.4. Global Antibody Fragments Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Antibody Fragments Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Antibody Fragments Total Addressable Market (TAM)

6. Antibody Fragments Market Segmentation

• 6.1. Global Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• F(ab) Fragments
• F(ab')2 Fragments
• Single-Chain Variable Fragments (scFvs)
• Single Domain Antibody Fragments (sdAbs)
• Other Types
• 6.2. Global Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibody
• Polyclonal Antibody
• 6.3. Global Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous (IV)
• Subcutaneous (SC)
• Oral
• Transdermal
• 6.4. Global Antibody Fragments Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer
• Immunodeficiencies
• Other Applications
• 6.5. Global Antibody Fragments Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Biotechnology Companies
• Research Institutions
• Diagnostic Laboratories
• Contract Research Organizations (CROs)
• 6.6. Global Antibody Fragments Market, Sub-Segmentation Of F(ab) Fragments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recombinant F(ab) Fragments
• Enzymatically Derived F(ab) Fragments
• 6.7. Global Antibody Fragments Market, Sub-Segmentation Of F(ab')2 Fragments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pepsin-Derived F(ab')2 Fragments
• Recombinant F(ab')2 Fragments
• 6.8. Global Antibody Fragments Market, Sub-Segmentation Of Single-Chain Variable Fragments (scFvs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bacterial-Produced Single-Chain Variable Fragments (scFvs)
• Mammalian Cell-Produced Single-Chain Variable Fragments (scFvs)
• Yeast-Produced Single-Chain Variable Fragments (scFvs)
• 6.9. Global Antibody Fragments Market, Sub-Segmentation Of Single Domain Antibody Fragments (sdAbs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Camelid-Derived Single Domain Antibody Fragments (sdAbs)
• Shark-Derived Single Domain Antibody Fragments (sdAbs)
• Synthetic Single Domain Antibody Fragments (sdAbs)
• 6.10. Global Antibody Fragments Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bispecific Antibody Fragments
• Multispecific Antibody Fragments
• Fusion Protein Antibody Fragments

7. Antibody Fragments Market Regional And Country Analysis

• 7.1. Global Antibody Fragments Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Antibody Fragments Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antibody Fragments Market

• 8.1. Asia-Pacific Antibody Fragments Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antibody Fragments Market

• 9.1. China Antibody Fragments Market Overview
• 9.2. China Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antibody Fragments Market

• 10.1. India Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antibody Fragments Market

• 11.1. Japan Antibody Fragments Market Overview
• 11.2. Japan Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antibody Fragments Market

• 12.1. Australia Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antibody Fragments Market

• 13.1. Indonesia Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antibody Fragments Market

• 14.1. South Korea Antibody Fragments Market Overview
• 14.2. South Korea Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antibody Fragments Market

• 15.1. Western Europe Antibody Fragments Market Overview
• 15.2. Western Europe Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antibody Fragments Market

• 16.1. UK Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antibody Fragments Market

• 17.1. Germany Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antibody Fragments Market

• 18.1. France Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antibody Fragments Market

• 19.1. Italy Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antibody Fragments Market

• 20.1. Spain Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antibody Fragments Market

• 21.1. Eastern Europe Antibody Fragments Market Overview
• 21.2. Eastern Europe Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antibody Fragments Market

• 22.1. Russia Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antibody Fragments Market

• 23.1. North America Antibody Fragments Market Overview
• 23.2. North America Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antibody Fragments Market

• 24.1. USA Antibody Fragments Market Overview
• 24.2. USA Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antibody Fragments Market

• 25.1. Canada Antibody Fragments Market Overview
• 25.2. Canada Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antibody Fragments Market

• 26.1. South America Antibody Fragments Market Overview
• 26.2. South America Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antibody Fragments Market

• 27.1. Brazil Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antibody Fragments Market

• 28.1. Middle East Antibody Fragments Market Overview
• 28.2. Middle East Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antibody Fragments Market

• 29.1. Africa Antibody Fragments Market Overview
• 29.2. Africa Antibody Fragments Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Antibody Fragments Market, Segmentation By Specificity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Antibody Fragments Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antibody Fragments Market Competitive Landscape And Company Profiles

• 30.1. Antibody Fragments Market Competitive Landscape
• 30.2. Antibody Fragments Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Antibody Fragments Market Other Major And Innovative Companies

• 31.1. AstraZeneca PLC
• 31.2. Novartis AG
• 31.3. GSK plc
• 31.4. Eli Lilly and Company
• 31.5. Amgen Inc.
• 31.6. Boehringer Ingelheim International GmbH
• 31.7. Regeneron Pharmaceuticals Inc.
• 31.8. Biogen Inc.
• 31.9. UCB S.A.
• 31.10. Bio-Rad Laboratories Inc.
• 31.11. Genmab A/S
• 31.12. WuXi Biologics Co. Ltd.
• 31.13. Abcam plc
• 31.14. MacroGenics Inc.
• 31.15. Harbour BioMed

32. Global Antibody Fragments Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antibody Fragments Market

34. Recent Developments In The Antibody Fragments Market

35. Antibody Fragments Market High Potential Countries, Segments and Strategies

• 35.1 Antibody Fragments Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Antibody Fragments Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Antibody Fragments Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34759_Antibody_Fragments_GMR_2025

관련자료